National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2011 - specification under subsection 84AAA(2) (No. PB 55 of 2011)

Overview

The National Health (Pharmaceutical Benefits – Early Supply) Amendment August 2011 – Specification under Subsection 84AAA(2) was enacted to address the need for updating the list of pharmaceutical items that are eligible for early supply under the Pharmaceutical Benefits Scheme (PBS) without triggering PBS Safety Net entitlements. This legislative instrument, created under subsection 84AAA(2) of the National Health Act 1953, amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 (PB 30 of 2009). The amendment introduces a new pharmaceutical item, specifically 'Dutasteride with Tamsulosin' in capsule form, administered orally, into the list of pharmaceutical benefits for early supply. The Pharmaceutical Benefits Advisory Committee (PBAC) recommended this addition, ensuring the legislative change is grounded in expert consultation and aligns with the broader objectives of the PBS. The PBAC, comprising members from various health-related professions, provides recommendations to the Minister, who then specifies the pharmaceutical items through legislative instruments. This amendment ensures that early supply of the specified pharmaceutical item adheres to the criteria set out in the National Health Act 1953, maintaining the integrity and efficiency of the PBS.

Scope and Application

The National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2011 is a legislative instrument that amends the National Health Act 1953 by inserting a new pharmaceutical item into the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009. This instrument specifies pharmaceutical items for which Pharmaceutical Benefits Scheme (PBS) Safety Net entitlements will not apply for early supplies. The purpose of this amendment is to include the pharmaceutical item ‘Dutasteride with Tamsulosin’ in the list of items exempt from PBS Safety Net entitlements when supplied early. This legislative instrument applies to the Commonwealth of Australia and affects entities involved in the supply of pharmaceutical benefits, particularly those within the Pharmaceutical Benefits Scheme. The amendment is made under the authority provided by subsection 84AAA(2) of the National Health Act 1953, and it extends the existing framework governing early supplies of specified pharmaceutical benefits. The amendment is in response to recommendations made by the Pharmaceutical Benefits Advisory Committee, which includes experts from various relevant fields to ensure a balanced and informed decision-making process.

Key Provisions

The primary sections of the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2011 (PB 55 of 2011) amend the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 (PB 30 of 2009) by adding a new pharmaceutical item to the list of items for which Pharmaceutical Benefits Scheme (PBS) Safety Net entitlements will not apply for early supplies. Specifically, section 1 of the amendment instrument inserts the pharmaceutical item "Dutasteride with Tamsulosin" in capsule form, administered orally, into the list of specified items. This amendment ensures that supplies of this pharmaceutical item will be considered early supplies if certain criteria are met, such as being supplied within 20 days of a previous supply of the same or an equivalent item, as detailed in section 2 of the amendment. The obligations imposed by this amendment primarily concern the Pharmaceutical Benefits Advisory Committee (PBAC) and suppliers of pharmaceutical benefits. The PBAC is responsible for recommending pharmaceutical items that should be specified in the instrument under subsection 84AAA(2) of the National Health Act 1953. The PBAC’s recommendations are critical in ensuring that the list of items in PB 30 of 2009 remains current and relevant. Suppliers of pharmaceutical benefits, on the other hand, must adhere to the criteria set forth in subsection 84AAA(1) of the Act to determine whether a supply constitutes an early supply of a specified pharmaceutical benefit. This involves checking the timing of the supply against the previous supply of the same or an equivalent item and ensuring that the supply does not result from a prescription originating from a hospital. The amendment does not explicitly outline specific offences, penalties, or consequences for breach. However, it is implicit that any non-compliance with the criteria for early supply could result in a pharmaceutical benefit being incorrectly classified, potentially affecting the PBS Safety Net entitlements of patients. While the amendment itself does not introduce new penalties, any misclassification could lead to administrative or legal repercussions, as the PBS is subject to broader regulatory oversight and compliance requirements under the National Health Act 1953 and associated regulations. The overarching legislative framework would apply penalties and consequences for any breaches related to the supply of pharmaceutical benefits under the PBS.